The physiology and biochemistry of adrenarche

Endocrine Development

Volumn 20, Issue , 2010, Pages 20-27

  Auchus, Richard J ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE;

ADRENAL CORTEX; ADRENARCHE; ARTICLE; CHILDHOOD; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN DEVELOPMENT; PRIORITY JOURNAL; STEROIDOGENESIS; ZONA GLOMERULOSA;

ADRENAL GLANDS; ADRENARCHE; ANIMALS; BIOCHEMISTRY; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; MODELS, BIOLOGICAL; PUBERTY;

EID: 78751484971     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000321209     Document Type: Article

References (40)

1. Miller WL: Androgen synthesis in adrenarche. Rev Endocr Metab Disord 2009;10:3-17.
2. Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, DiMartino-Nardi J, Reiter E: Normative data for adrenal steroidogenesis in a healthy pediatric population: age-and sex-related changes after ACTH stimulation. J Clin Endocrinol Metab 1991;73:674-686.
3. Smail PJ, Faiman C, Hobson WC, Fuller GB, Winter JSD: Further studies on adrenarche in nonhuman primates. Endocrinology 1982;111:844-848.
4. Cutler GB, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL: Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology 1978;103:2112-2118.
5. Sklar CA, Kaplan SL, Grumbach MM: Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 1980;51:548-556.
6. Parker LN, Odell WD: Evidence for the existence of cortical androgen stimulating hormone. Am J Physiol 1979;236:616.
7. Mellon SH, Shively JE, Miller WL: Human proopiomelanocortin (79-96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells. J Clin Endocrinol Metab 1991;72:19-22.
8. Penhoat A, Sanchez P, Jaillard C, Langlois D, Begeot M, Saez JM: Human proopiomelanocortin (79-96), a proposed cortical androgen stimulating hormone, does not affect steroidogenesis in cultured human adult adrenal cells. J Clin Endocrinol Metab 1991;72: 23-26.
9. Orentreich N, Brind JL, Rizer RL, Vogelman JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59: 551-555.
10. Klose M, Jorgensen K, Kristensen LO: Characteristics of recovery of adrenocortical function after treatment for Cushings syndrome due to pituitary or adrenal adenomas. Clin Endocrinol (Oxf) 2004;61: 394-399.
11. Kleiber H, Rey F, Temler E, Gomez F: Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushings syndrome. J Endocrinol Invest 1991;14:489-492.
12. Remer T, Boye KR, Hartmann MF, Wudy SA: Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J Clin Endocrinol Metab 2005;90:2015-2021.
13. Miller WL: Steroid hormone biosynthesis and actions in the materno-feto-placental unit. Clin Perinatol 1998;25:799-817.
14. Nakamura Y, Hornsby PJ, Casson P, Morimoto R, Satoh F, Xing Y, Kennedy MR, Sasano H, Rainey WE: Type 5 17α-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 2009;94:2192-2198.
15. Townsend SF, Dallman MF, Miller WL: Insulin-like growth factor-I and -II mRNAs after two stimuli of adrenal growth; in Spencer E (ed): Modern Concepts of Insulin-Like Growth Factors. New York, Elsevier, 1991; pp 241-251.
16. Swart P, Swart AC, Waterman MR, Estabrook RW, Mason JI: Progesterone 16β-hydroxylase activity is catalyzed by human cytochrome P450 17α-hydroxylase. J Clin Endocrinol Metab 1993;77: 98-102.
17. Auchus RJ, Lee TC, Miller WL: Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 1998; 273:3158-3165.
18. Katagiri M, Kagawa N, Waterman MR: The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. Arch Biochem Biophys 1995;317: 343-347.
19. Yanagibashi K, Hall PF: Role of electron transport in the regulation of the lyase activity of C-21 sidechain cleavage P450 from porcine adrenal and testicular microsomes. J Biol Chem 1986;261: 8429-8433.
20. Naffin-Olivos JL, Auchus RJ: Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17. Biochemistry 2006;46:100-108.
21. Geller DH, Auchus RJ, Mendonca BB, Miller WL: The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 1997;17:201-205.
22. Sherbet DP, Tiosano D, Kwist KM, Hochberg Z, Auchus RJ: CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. J Biol Chem 2003;278:48563-48569.
23. Hershkovitz E, Parvari R, Wudy SA, Hartmann MF, Gomes LG, Loewental N, Miller WL: Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab 2008;93:3584-3588.
24. Kok RC, Timmerman MA, Wolffenbuttel KP, Drop SL, de Jong FH: Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X. J Clin Endocrinol Metab 2010;95:994-999.
25. Zhang L, Rodriguez H, Ohno S, Miller WL: Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and for the polycystic ovary syndrome. Proc Natl Acad Sci USA 1995;92:10619-10623.
26. Thomas JL, Berko EA, Faustino A, Myers RP, Strickler RC: Human placental 3β-hydroxy-5-enesteroid dehydrogenase and steroid 5/4-eneisomerase: purification from microsomes, substrate kinetics, and inhibition by product steroids. J Steroid Biochem 1988;31:785-793.
27. Lee TC, Miller WL, Auchus RJ: Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. J Clin Endocrinol Metab 1999;84:2104-2110.
28. Mizrachi D, Auchus RJ: Androgens, estrogens, and hydroxysteroid dehydrogenases. Mol Cell Endocrinol 2009;301:37-42.
29. Dardis A, Saraco N, Rivarola MA, Belgorosky A: Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: implications for the mechanism of adrenarche. Pediatr Res 1999;45:384-388.
30. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, Rainey WE: Adrenarche results from development of a 3β-hydroxysteroid dehydrogenasedeficient adrenal reticularis. J Clin Endocrinol Metab 1998;83:3695-3701.
31. Suzuki T, Sasano H, Takeyama J, Kaneko C, Freije WA, Carr BR, Rainey WE: Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies. Clin Endocrinol (Oxf) 2000;53:739-747.
32. Noordam C, Dhir V, McNelis JC, Schlereth F, Hanley NA, Krone N, Smeitink JA, Smeets R, Sweep FC, Claahsen-van der Grinten HL, Arlt W: Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 2009;360:2310-2318.
33. Ibanez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, Carrascosa A, Bernasconi S, Vicens-Calvet E: Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992;74: 254-257.
34. White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291.
35. Speiser PW, New MI, White P: Molecular genetic analysis of nonclassical steroid 21-hydroxylase deficiency associated with HLA-B14DR1. N Engl J Med 1988;319:19-23.
36. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Hermus AR: Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors. Fertil Steril 2007;88:705 e5-e8.
37. Auchus RJ: Congenital adrenal hyperplasia in adults. Curr Opin Endocrinol Diabet Obes 2010;17: 210-216.
38. Nair KS, Rizza RA, OBrien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD: DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;355:1647-1659.
39. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B: Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-1020.
40. Miller KK, Biller BM, Beauregard C, Lipman JG, J. J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A: Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006;91:1683-1690.